×
Waters Revenue 2010-2024 | WAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Waters revenue for the twelve months ending September 30, 2024 was
$2.905B
, a
3.01% decline
year-over-year.
Waters annual revenue for 2023 was
$2.956B
, a
0.52% decline
from 2022.
Waters annual revenue for 2022 was
$2.972B
, a
6.68% increase
from 2021.
Waters annual revenue for 2021 was
$2.786B
, a
17.78% increase
from 2020.
View More
Waters Revenue 2010-2024 | WAT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Waters annual revenue for 2023 was
$2.956B
, a
0.52% decline
from 2022.
Waters annual revenue for 2022 was
$2.972B
, a
6.68% increase
from 2021.
Waters annual revenue for 2021 was
$2.786B
, a
17.78% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$194.7B
Intuitive Surgical (ISRG)
$191.9B
Alcon (ALC)
$42.1B
Edwards Lifesciences (EW)
$41.4B
IQVIA Holdings (IQV)
$34.7B
IDEXX Laboratories (IDXX)
$34.1B
DexCom (DXCM)
$29.2B
STERIS (STE)
$20.9B
SONOVA HOLDING (SONVY)
$20.3B
Hologic (HOLX)
$18.2B
Fresenius Medical Care AG KGaA (FMS)
$13B
Sysmex ADR (SSMXY)
$12.7B
Globus Medical (GMED)
$11.3B
Penumbra (PEN)
$9.1B
Teleflex (TFX)
$9B
Masimo (MASI)
$8.8B
Glaukos (GKOS)
$8B
PROCEPT BioRobotics (PRCT)
$4.9B
Integer Holdings (ITGR)
$4.5B
Veracyte (VCYT)
$3B
Inari Medical (NARI)
$3B
LivaNova (LIVN)
$2.8B
TransMedics (TMDX)
$2.8B
Nihon Kohden (NHNKY)
$2.3B
Elekta AB (EKTAY)
$2.2B
Tandem Diabetes Care (TNDM)
$1.8B
RxSight (RXST)
$1.8B
Integra LifeSciences Holdings (IART)
$1.8B
Alphatec Holdings (ATEC)
$1.4B
Artivion (AORT)
$1.1B